Title : AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model - Bradley_2010_Neuropharmacol_58_365 |
Author(s) : Bradley SR , Lameh J , Ohrmund L , Son T , Bajpai A , Nguyen D , Friberg M , Burstein ES , Spalding TA , Ott TR , Schiffer HH , Tabatabaei A , McFarland K , Davis RE , Bonhaus DW |
Ref : Neuropharmacology , 58 :365 , 2010 |
Abstract : |
PubMedSearch : Bradley_2010_Neuropharmacol_58_365 |
PubMedID: 19835892 |
Title : Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands - Davis_2009_BMC.Pharmacol_9_14 |
Author(s) : Davis CN , Bradley SR , Schiffer HH , Friberg M , Koch K , Tolf BR , Bonhaus DW , Lameh J |
Ref : BMC Pharmacol , 9 :14 , 2009 |
Abstract : |
PubMedSearch : Davis_2009_BMC.Pharmacol_9_14 |
PubMedID: 19951444 |
Title : Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine: evidence for three distinct modes of receptor activation - Spalding_2006_Mol.Pharmacol_70_1974 |
Author(s) : Spalding TA , Ma JN , Ott TR , Friberg M , Bajpai A , Bradley SR , Davis RE , Brann MR , Burstein ES |
Ref : Molecular Pharmacology , 70 :1974 , 2006 |
Abstract : |
PubMedSearch : Spalding_2006_Mol.Pharmacol_70_1974 |
PubMedID: 16959945 |